KUALA LUMPUR: No cases of stroke were reported in clinic studies for the Comirnaty bivalent Covid-19 vaccine, according to data submitted by product registration holder Pfizer Sdn Bhd to the National Pharmaceutical Regulatory Agency (NPRA). Read full story